InsidersTradesSigma
Browse the full record of transactions filed by Engelhart James, Chief Financial Officer. Officer active across 1 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. Aggregated, 6 reports have been logged. The latest transaction was filed on 6 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
6 of 6 declarations
Engelhart James is the Chief Financial Officer and Strategic Advisor at Biohaven Pharmaceutical Holding Co Ltd. In this role, he oversees financial operations and contributes to the growth strategy of the company. His expertise in finance and risk management is essential for ensuring the financial health and sustainability of Biohaven.